Blastic plasmacytoid dendritic cell neoplasm (BPDCN) was previously known as natural killer (NK) cell leukemia/lymphoma. As understanding of the biology and origin of this malignancy has …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy. It was initially regarded as a form of lymphocyte-derived cutaneous lymphoma and alternatively …

2005年7月5日 · Blastic natural killer (NK) cell lymphoma/leukemia (BNKL) is an immature CD56-positive neoplasm, which was recognized recently and characterized by systemic proliferation …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN), previously known as blastic natural killer (NK) cell lymphoma or CD4 + /CD56 + hematodermic neoplasm, is an exceedingly rare …

2024年3月3日 · Blastic plasmacytoid dendritic cell neoplasm is an uncommon CD4+ CD56+ myeloid cancer that typically manifests as cutaneous lesions with or without involvement of …

The disease was initially recognized in 1994 as a CD4+ natural killer (NK) cell leukemia and quickly became known as a blastic NK cell lymphoma due to its blastic appearance as well as …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN), formerly known as blastic NK cell lymphoma or CD4+/CD56+ hematodermic neoplasm, is a rare aggressive disorder of a not …

Blastic NK (<<natural killer>>) cell lymphoma is a rare type of lymphoma, recognized as an independent entity in the new World Health Organization-European Organization for Research …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare subtype of acute leukemia and was formerly known as blastic natural killer (NK)-cell lymphoma and CD4 + …

The clinical course in two patients culminated in an overtly leukemic phase. These findings suggest that blastic NKL/L represents a distinct clinicopathologic entity, characterized by …